The Martin Healthcare Group

themhg.com

For 40 years our clients and physicians have known us as Physician Staffing or Community Hospitalists. While all our family owned and operated divisions will not change, we have created an umbrella identity, The Martin Healthcare Group, which encompasses all our companies. Our dedication to service and excellence will not change, nor has our ownership. Our companies include.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

MIKART AND NANO PHARMASOLUTIONS HAVE ENTERED INTO A COLLABORATION AGREEMENT TO MANUFACTURE CLINICAL TRIAL MATERIALS USING NANOTRANSFORMER™ TECHNOLOGY

Mikart, LLC Nano and PharmaSolutions, Inc. | October 12, 2022

news image

Mikart, LLC a comprehensive contract development and manufacturing organization announced that it has entered into a collaboration agreement with Nano PharmaSolutions, Inc. an innovative nanotechnology company that has a proprietary NanoTransformer™ that enhances the solubility of pharmaceutical active ingredients. "We are excited to bring this new technology from preclinical stage to a GMP clinical phase manufacturing environment. This differentia...

Read More

NEW JERSEY PHARMACEUTICAL COMPANY DONATES 400,000 TABLETS TO LOUISIANA FOR CLINICAL TRIALS IN COVID-19 TREATMENT

WBRZ- | March 30, 2020

news image

Louisiana Attorney General Jeff Landry, working with the assistance of State Senate Health and Welfare Chairman Fred Mills issued a statement Monday, announcing that Amneal Pharmaceuticals is donating 400,000 hydroxychloroquine sulfate tablets to the State of Louisiana to assist with the COVID-19 pandemic. "On behalf of Louisiana, I want to thank Amneal for this generous donation," said General Landry. "Amneal's donation is one step toward trying to find treatments and cures f...

Read More

Business Insights

SUVODA AND N-SIDE ANNOUNCE AGREEMENT TO DELIVER INTEGRATED CLINICAL TRIAL OPTIMIZATION AND IRT SOLUTIONS FOR REAL-TIME DEMAND PLANNING

Suvoda LLC | May 13, 2022

news image

Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system, and rare disease, today announced they have entered into an agreement to partner with N-SIDE — a deeptech company that empowers organizations in the clinical trials industry to make better decisions and optimize the use of critical resources.  To date, the two companies have successfully partnered on more than 100 clinical ...

Read More

FORWARDVUE PHARMA SECURES FUNDING TO ADVANCE PRE-CLINICAL DEVELOPMENT PROGRAMS

prnewswire | August 26, 2020

news image

ForwardVue Pharma has secured initial seed round funding in order to advance pre-clinical development of potent long acting anti-angiogenic molecules directed against diabetic eye disease and neovascular age related macular degeneration. As the Founder of ForwardVue Pharma, Alan has performed 40,000+ intravitreal injections as a practicing retina specialist with over 20 years of experience. He has served as principle investigator in a number of diabetic retinopathy and AMD trials, presents his w...

Read More
news image

Business Insights

MIKART AND NANO PHARMASOLUTIONS HAVE ENTERED INTO A COLLABORATION AGREEMENT TO MANUFACTURE CLINICAL TRIAL MATERIALS USING NANOTRANSFORMER™ TECHNOLOGY

Mikart, LLC Nano and PharmaSolutions, Inc. | October 12, 2022

Mikart, LLC a comprehensive contract development and manufacturing organization announced that it has entered into a collaboration agreement with Nano PharmaSolutions, Inc. an innovative nanotechnology company that has a proprietary NanoTransformer™ that enhances the solubility of pharmaceutical active ingredients. "We are excited to bring this new technology from preclinical stage to a GMP clinical phase manufacturing environment. This differentia...

Read More
news image

NEW JERSEY PHARMACEUTICAL COMPANY DONATES 400,000 TABLETS TO LOUISIANA FOR CLINICAL TRIALS IN COVID-19 TREATMENT

WBRZ- | March 30, 2020

Louisiana Attorney General Jeff Landry, working with the assistance of State Senate Health and Welfare Chairman Fred Mills issued a statement Monday, announcing that Amneal Pharmaceuticals is donating 400,000 hydroxychloroquine sulfate tablets to the State of Louisiana to assist with the COVID-19 pandemic. "On behalf of Louisiana, I want to thank Amneal for this generous donation," said General Landry. "Amneal's donation is one step toward trying to find treatments and cures f...

Read More
news image

Business Insights

SUVODA AND N-SIDE ANNOUNCE AGREEMENT TO DELIVER INTEGRATED CLINICAL TRIAL OPTIMIZATION AND IRT SOLUTIONS FOR REAL-TIME DEMAND PLANNING

Suvoda LLC | May 13, 2022

Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system, and rare disease, today announced they have entered into an agreement to partner with N-SIDE — a deeptech company that empowers organizations in the clinical trials industry to make better decisions and optimize the use of critical resources.  To date, the two companies have successfully partnered on more than 100 clinical ...

Read More
news image

FORWARDVUE PHARMA SECURES FUNDING TO ADVANCE PRE-CLINICAL DEVELOPMENT PROGRAMS

prnewswire | August 26, 2020

ForwardVue Pharma has secured initial seed round funding in order to advance pre-clinical development of potent long acting anti-angiogenic molecules directed against diabetic eye disease and neovascular age related macular degeneration. As the Founder of ForwardVue Pharma, Alan has performed 40,000+ intravitreal injections as a practicing retina specialist with over 20 years of experience. He has served as principle investigator in a number of diabetic retinopathy and AMD trials, presents his w...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us